MUSC Health advances biomedical knowledge by serving as a setting for clinical and translational research, providing resources for conducting research and opportunities for patients to participate in research and treatment protocols.
Hollings Cancer Center – South Carolina’s Only NCI-Designated Cancer Center
Research affiliations with MUSC Health allow other health care entities to access MUSC Health-based clinical trials, either as co-participants or as direct access points for their patients.
The Hollings Cancer Center Clinical Trials Network (CTN) represents a partnership of quality cancer centers dedicated to the promotion of cancer research. By establishing a collaborative infrastructure of physicians, clinical trials offices, and patients, the CTN reaches large and diverse patient populations, which increases the rate of trial enrollment — a key to the success of any clinical trial.
The CTN caters to both the clinical trial site and research sponsor. MUSC Health can design a unique service plan to meet your organization’s needs. CTN members gain access to a number of unique clinical trials, which may include trials developed at the Hollings Cancer Center, e.g., our investigator-initiated trials. Members also have the opportunity to participate in other phase II and phase III studies made available to the CTN through MUSC Health’s academic or industrial partnerships.